Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing globally. MASLD is characterized by clinically significant liver steatosis, and a subset of patients progress to more severe metabolic-disorder-associated steatohepatitis (MASH) with liver inflammation a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS pharmacology & translational science 2024-09, Vol.7 (9), p.2856-2868
Hauptverfasser:	Laudermilk, Lucas T., Schlosburg, Joel E., Gay, Elaine A., Decker, Ann M., Williams, Aaron, Runton, Rubica, Vasukuttan, Vineetha, Kotiya, Archana, Amato, George S., Maitra, Rangan
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!